Clinical and Experimental Reproductive Medicine

Improved ovarian adiponectin system expression in polycystic ovary syndrome treated with exenatide: Asma Vatankhah, Mohabbat Jamhiri, Sima Vatankhah, Keivan Lorian, Mohammad Ebrahim Rezvani, Mahin Izadi; Received February 1, 2024 Accepted June 9, 2024; DOI: https://doi.org/10.5653/cerm.2024.06912 [Epub ahead of print]
Crossref 1; Full text PubReader ePub PDF

Systematic Review of the roles of Inositol and Vitamin D in improving fertility among patients with Polycystic Ovary Syndrome: Gitika Katyal, Gursharan Kaur, Hafsa Ashraf, Adiprasad Bodapati, Ayesha Hanif, Donatus Kaine Okafor, Safeera Khan; Clin Exp Reprod Med. 2024;51(3):181-191. Published online April 11, 2024; DOI: https://doi.org/10.5653/cerm.2023.06485; Full text PubReader ePub PDF

Comparative analysis of conventional in vitro fertilization and intracytoplasmic sperm injection in patients with polycystic ovarian syndrome, tubal factor infertility, and unexplained infertility whose partners exhibit normal semen parameters: a r: Sareh Ashourzadeh, Somayyeh Safari, Robabe Hosseinisadat, Raheleh Kafaeinezhad, Saeed Shokri, Sanaz Alaee; Received July 29, 2023 Accepted January 30, 2024; DOI: https://doi.org/10.5653/cerm.2023.06408 [Epub ahead of print]; Full text PubReader ePub PDF

Ovarian volume is more closely related to the different manifestations of polycystic ovary syndrome than follicle number per ovary: Shazia Afrine, Jasmine Ara Haque, Md Shahed Morshed, Hurjahan Banu, Ahmed Hossain, Muhammad Abul Hasanat; Clin Exp Reprod Med. 2023;50(3):200-205. Published online June 13, 2023; DOI: https://doi.org/10.5653/cerm.2023.05897; Full text PubReader ePub PDF

Relationship between hematologic parameters related to systemic inflammation and insulin resistance-associated metabolic parameters in women with polycystic ovary syndrome: Minkyung Cho, Suji Kim, Sungwook Chun; Clin Exp Reprod Med. 2023;50(3):206-212. Published online May 19, 2023; DOI: https://doi.org/10.5653/cerm.2023.05932
Web of Science 1 Crossref 2; Full text PubReader ePub PDF

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome: Jeong Eun Lee, Yubin Park, Jisoo Lee, Sungwook Chun; Clin Exp Reprod Med. 2023;50(2):117-122. Published online May 11, 2023; DOI: https://doi.org/10.5653/cerm.2023.05855
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Therapeutic effect of Ferula assa-foetida oleo-gum resin in rats with letrozole-induced polycystic ovary syndrome: Amir Shieh, Seyyed Majid Bagheri, Maryam Yadegari, Davoud Javidmehr, Zeinab Farhadi; Clin Exp Reprod Med. 2022;49(4):239-247. Published online November 24, 2022; DOI: https://doi.org/10.5653/cerm.2022.05449
Web of Science 6 Crossref 2; Full text PubReader ePub PDF

The impact of hyperandrogenism on the outcomes of ovulation induction using gonadotropin and intrauterine insemination in women with polycystic ovary syndrome: Vu Ngoc Anh Ho, Toan Duong Pham, Nam Thanh Nguyen, Hieu Le Trung Hoang, Tuong Manh Ho, Lan Ngoc Vuong; Clin Exp Reprod Med. 2022;49(2):127-134. Published online May 27, 2022; DOI: https://doi.org/10.5653/cerm.2022.05204; Full text PubReader ePub PDF Supplementary Material

Association between the serum estrone-to-estradiol ratio and parameters related to glucose metabolism and insulin resistance in women with polycystic ovary syndrome: Nayoung Kim, Sungwook Chun; Clin Exp Reprod Med. 2021;48(4):374-379. Published online December 1, 2021; DOI: https://doi.org/10.5653/cerm.2021.04553
Web of Science 6 Crossref 5; Full text PubReader ePub PDF

Anorexigenic peptide (leptin, obestatin, nesfatin-1) levels and their impact on assisted reproductive technology treatment outcomes in patients with polycystic ovary syndrome: Bulut Varlı, Yavuz Emre Şükür, Batuhan Özmen, Berrin İmge Ergüder, Murat Sönmezer, Bülent Berker, Cem Atabekoğlu, Ruşen Aytaç; Clin Exp Reprod Med. 2021;48(4):368-373. Published online November 30, 2021; DOI: https://doi.org/10.5653/cerm.2021.04420
Web of Science 6 Crossref 3; Full text PubReader ePub PDF

Update on polycystic ovary syndrome: Jin Ju Kim; Clin Exp Reprod Med. 2021;48(3):194-197. Published online August 24, 2021; DOI: https://doi.org/10.5653/cerm.2020.04329
Web of Science 4 Crossref 6; Full text PubReader ePub PDF

The effect of genistein on insulin resistance, inflammatory factors, lipid profile, and histopathologic indices in rats with polycystic ovary syndrome: Sasan Amanat, Fatemeh Ashkar, Mohammad Hassan Eftekhari, Nader Tanideh, Saeid Doaei, Maryam Gholamalizadeh, Farhad Koohpeyma, Maral Mokhtari; Clin Exp Reprod Med. 2021;48(3):236-244. Published online August 20, 2021; DOI: https://doi.org/10.5653/cerm.2020.04231
Web of Science 11 Crossref 11; Full text PubReader ePub PDF

Alteration of TGFB1, GDF9, and BMPR2 gene expression in preantral follicles of an estradiol valerate-induced polycystic ovary mouse model can lead to anovulation, polycystic morphology, obesity, and absence of hyperandrogenism: Reza Asghari, Vahid Shokri-Asl, Hanieh Rezaei, Mahmood Tavallaie, Mostafa Khafaei, Amir Abdolmaleki, Abbas Majdi Seghinsara; Clin Exp Reprod Med. 2021;48(3):245-254. Published online August 6, 2021; DOI: https://doi.org/10.5653/cerm.2020.04112
Web of Science 7 Crossref 9; Full text PubReader ePub PDF

Predictive capability of fasting-state glucose and insulin measurements for abnormal glucose tolerance in women with polycystic ovary syndrome: Sungwook Chun; Clin Exp Reprod Med. 2021;48(2):156-162. Published online June 1, 2021; DOI: https://doi.org/10.5653/cerm.2020.04308
Web of Science 2 Crossref 2; Full text PubReader ePub PDF

The effect of insemination methods on in vitro maturation outcomes: Pallop Pongsuthirak; Clin Exp Reprod Med. 2020;47(2):130-134. Published online May 14, 2020; DOI: https://doi.org/10.5653/cerm.2019.03300
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Search